首页
>
>
投稿咨询
微信添加科研助理

了解相关问题

加急服务
微信添加科研助理

了解相关问题

CURRENT DRUG METABOLISM
ISSN：1389-2002

CURRENT DRUG METABOLISM

CURR DRUG METAB
学科领域：医学
是否预警：不在预警名单内
是否OA：否
录用周期：偏慢,4-8周
新锐分区：医学4区
年发文量：55
影响因子：1.8
JCR分区：Q3

基本信息

当前药物代谢旨在涵盖药物代谢、药代动力学和药物处置方面的所有最新和突出进展。该杂志是发表药物代谢方面的长篇/小型综述、研究文章和客座编辑问题的国际论坛。《现代药物代谢》是学术、临床、政府和制药科学家的重要期刊，他们希望了解最重要的进展。该杂志涵盖以下一般主题领域：药学、药代动力学、毒理学和最重要的药物代谢。更具体地，I期和II期酶或代谢途径的体外和体内药物代谢;药物相互作用和酶动力学;药代动力学、药代动力学-药效学建模和毒代动力学;代谢或药代动力学的种间差异、种属缩放和外推;药物转运蛋白;靶器官毒性和药物暴露-反应的个体间变异性;肝外代谢;生物活化、反应性代谢物和药物代谢物鉴定的发展。描述上市药物或药物类别的药物代谢和药代动力学的临床前和临床综述。
1389-2002SCIE/Scopus收录
1.8
点击查看最新影响趋势>
2.2
新
2026年3月发布
点击查看历史分区趋势    >
大类学科小类学科Top期刊综述期刊
医学4区
BIOCHEMISTRY & MOLECULAR BIOLOGY 生化与分子生物学
4区
PHARMACOLOGY & PHARMACY 药学
4区
否
N/A
新
WOS期刊SCI分区  2024-2025最新升级版
按JIF指标学科分区收集子录JIF分区JIF排名百分位
学科：BIOCHEMISTRY & MOLECULAR BIOLOGY
SCIE
Q4
264/320
学科：PHARMACOLOGY & PHARMACY
SCIE
Q3
244/352
按JCR指标学科分区收集子录JCR分区JCR排名百分位
学科：BIOCHEMISTRY & MOLECULAR BIOLOGY
SCIE
Q4
279/321
学科：PHARMACOLOGY & PHARMACY
SCIE
Q4
284/353
97
55
点击查看年发文量趋势图>
25%一般偏慢,4-8周-医学-生化与分子生物学
5.6%
点击查看自引率趋势图>
时间预警情况
2026年03月发布的新锐学术版不在预警名单中
2025年03月发布的2025版不在预警名单中
2024年02月发布的2024版不在预警名单中
2023年01月发布的2023版不在预警名单中
2021年12月发布的2021版不在预警名单中
2020年12月发布的2020版不在预警名单中
74.55%2.87%-
CiteScore：4.40
SJR：0.522
SNIP：0.518
学科类别分区排名百分位
大类：Biochemistry, Genetics and Molecular Biology
小类：Clinical Biochemistry
Q2
61 / 121
大类：Biochemistry, Genetics and Molecular Biology
小类：Pharmacology
Q3
162 / 321

期刊高被引文献

The Impact of Carboxylesterases in Drug Metabolism and Pharmacokinetics
来源期刊：Current Drug MetabolismDOI：10.2174/1389200219666180821094502
Targeting Virus-host Protein Interactions: Feature Extraction and Machine Learning Approaches.
来源期刊：Current drug metabolismDOI：10.2174/1389200219666180829121038
Herb-Drug Interactions and Hepatotoxicity.
来源期刊：Current drug metabolismDOI：10.2174/1389200220666190325141422
Recent Advances in the Machine Learning-Based Drug-Target Interaction Prediction.
来源期刊：Current drug metabolismDOI：10.2174/1389200219666180821094047
Drug-Drug Interactions of P-gp Substrates Unrelated to CYP Metabolism.
来源期刊：Current drug metabolismDOI：10.2174/1389200219666181003142036
Cross-regulatory Circuit Between AHR and Microbiota.
来源期刊：Current drug metabolismDOI：10.2174/1389200219666180129151150
Application of Traditional Chinese Herbal Medicine By-products as Dietary Feed Supplements and Antibiotic Replacements in Animal Production.
来源期刊：Current drug metabolismDOI：10.2174/1389200219666180523102920
A Review of Recent Advances and Research on Drug Target Identification Methods.
来源期刊：Current drug metabolismDOI：10.2174/1389200219666180925091851
Advanced Glycation End Products (AGEs), Glutathione and Breast Cancer: Factors, Mechanism and Therapeutic Interventions.
来源期刊：Current drug metabolismDOI：10.2174/1389200219666180912104342
The Therapeutic Role of Xenobiotic Nuclear Receptors Against Metabolic Syndrome.
来源期刊：Current drug metabolismDOI：10.2174/1389200219666180611083155
PI3K/Akt-Nrf2 and Anti-Inflammation Effect of Macrolides in Chronic Obstructive Pulmonary Disease.
来源期刊：Current drug metabolismDOI：10.2174/1389200220666190227224748
The Relationship Between the Serotonin Metabolism, Gut-Microbiota and the Gut-Brain Axis.
来源期刊：Current drug metabolismDOI：10.2174/1389200220666190725115503
Preclinical Pharmacokinetics of Triptolide: A Potential Antitumor Drug.
来源期刊：Current drug metabolismDOI：10.2174/1389200219666180816141506
Genitourinary Tumors: Update on Molecular Biomarkers for Diagnosis, Prognosis and Prediction of Response to Therapy.
来源期刊：Current drug metabolismDOI：10.2174/1389200220666190225124352
Impact of Drug Metabolism/Pharmacokinetics and their Relevance Upon Traditional Medicine-based Cardiovascular Drug Research.
来源期刊：Current drug metabolismDOI：10.2174/1389200220666190618101526
Curcumin - A Novel Therapeutic Agent In The Prevention Of Colorectal Cancer.
来源期刊：Current drug metabolismDOI：10.2174/1389200220666191007153238
Nanomedicine: Bioavailability, Biotransformation and Biokinetics.
来源期刊：Current drug metabolismDOI：10.2174/1389200220666190614150708
Kisspeptin and its Effect on Mammalian Spermatogensis.
来源期刊：Current drug metabolismDOI：10.2174/1389200219666180129112406
A Change in Bile Flow: Looking Beyond Transporter Inhibition in the Development of Drug-induced Cholestasis.
来源期刊：Current drug metabolismDOI：10.2174/1389200220666190709170256
Effects of Gut Microbiota on Drug Metabolism and Guidance for Rational Drug Use Under Hypoxic Conditions at High Altitudes.
来源期刊：Current drug metabolismDOI：10.2174/1389200219666181019145159
Survey of Drug Oxidation Activities in Hepatic and Intestinal Microsomes of Individual Common Marmosets, a New Nonhuman Primate Animal Model
来源期刊：Current Drug MetabolismDOI：10.2174/1389200219666181003143312
Neuroblastoma: An updated review on biology and treatment.
来源期刊：Current drug metabolismDOI：10.2174/1389200221666191226102231
Clinical Implications of Methotrexate Pharmacogenetics in Childhood Acute Lymphoblastic Leukaemia.
来源期刊：Current drug metabolismDOI：10.2174/1389200220666190130161758
A systematic investigation of the effects of long-term administration of a high-fat diet on drug transporters in the mouse liver, kidney and intestine.
来源期刊：Current drug metabolismDOI：10.2174/1389200220666190902125435
The Role of the Sodium-taurocholate Co-transporting Polypeptide (NTCP) and Bile Salt Export Pump (BSEP) in Related Liver Disease.
来源期刊：Current drug metabolismDOI：10.2174/1389200220666190426152830
Decreased Disposition of Anticancer Drugs Predominantly Eliminated via the Liver in Patients with Renal Failure
来源期刊：Current Drug MetabolismDOI：10.2174/1389200220666190402143125
Influence of the OATP Polymorphism on the Population Pharmacokinetics of Methotrexate in Chinese Patients
来源期刊：Current Drug MetabolismDOI：10.2174/1389200220666190701094756
Superparamagnetic Iron Oxide Nanoparticles (SPIONs) for Diagnosis and Treatment of Breast, Ovarian and Cervical Cancers.
来源期刊：Current drug metabolismDOI：10.2174/1389200220666191016124958
Evaluation Of Pharmacokinetic Interaction of Cilostazol with Metoclopramide after Oral Administration in Human.
来源期刊：Current drug metabolismDOI：10.2174/1389200220666191105115805
Assessment of miR-212 and Other Biomarkers in the Diagnosis and Treatment of HBV-infection-related Liver Diseases.
来源期刊：Current drug metabolismDOI：10.2174/1389200220666191011120434
The Development of Machine Learning Methods in Cell-Penetrating Peptides Identification: A Brief Review.
来源期刊：Current drug metabolismDOI：10.2174/1389200219666181010114750
Emerging Trends in Nanotechnology: Nanozymes, Imaging Probes and Biosensors and Nanocarriers.
来源期刊：Current drug metabolismDOI：10.2174/138920022006190617104713
Interethnic variations of UGT1A1 and UGT1A7 Polymorphisms in the Jordanian Population.
来源期刊：Current drug metabolismDOI：10.2174/1389200220666190528085151
Recognition Sites for Cancer-Targeting Durg Delivery Systems.
来源期刊：Current drug metabolismDOI：10.2174/1389200220666191003161114
Effects of CYP2C8 and SLCO1B1 Genetic Polymorphisms on Repaglinide Pharmacokinetics: A Systematic Review and Meta-Analysis.
来源期刊：Current drug metabolismDOI：10.2174/1389200220666190111114146
Recent Advances on Prediction of Human Papillomaviruses Risk Types.
来源期刊：Current drug metabolismDOI：10.2174/1389200220666190118110012
Associations of CYP2A6 Gene Polymorphism with Smoking Status among Jordanians: Gender-Related Differences.
来源期刊：Current drug metabolismDOI：10.2174/1389200220666190827161112
Interaction Between Traditional Chinese Medicine and Anticoagulant/antiplatelet Drugs.
来源期刊：Current drug metabolismDOI：10.2174/1389200220666190827160212
Curcumin-C3 Complexed With α-, β-cyclodextrin Exhibits Antibacterial and Antioxidant Properties Suitable for Cancer Treatments.
来源期刊：Current drug metabolismDOI：10.2174/1389200220666191001104834
Recent Findings on Nanotechnology-based Therapeutic Strategies Against Hepatocellular Carcinoma.
来源期刊：Current drug metabolismDOI：10.2174/1389200220666190308134351
Role of Cellular Biomolecules in Screening, Diagnosis, and Treatment of Colorectal Cancer.
来源期刊：Current drug metabolismDOI：10.2174/1389200220666191018153428
A Retrospective Look at Anti-EGFR Agents in Pancreatic Cancer Therapy.
来源期刊：Current drug metabolismDOI：10.2174/1389200220666191122104955
Oral Delivery of Anticancer Agents using Nanoparticulate Drug Delivery System.
来源期刊：Current drug metabolismDOI：10.2174/1389200220666191007154017
Naphthalene Toxicity in Clinical Practice.
来源期刊：Current drug metabolismDOI：10.2174/1389200220666191122110036
Warfarin Dosing and Outcomes in Chronic Kidney Disease: A Closer Look at Warfarin Disposition.
来源期刊：Current drug metabolismDOI：10.2174/1389200220666190701095807
Delivery of Local Anesthesia: Current Strategies, Safety, and Future Prospects.
来源期刊：Current drug metabolismDOI：10.2174/1389200220666190610155049
Higher Atazanavir plasma exposure in Rats is associated with Gut Microbiota Changes induced by Cotrimoxazole.
来源期刊：Current drug metabolismDOI：10.2174/1389200220666191023105609
Hepatic Artery and Peripheral Vein Pharmacokinetics of Raltitrexed in Swine After the Administration of a Hepatic Arterial Infusion.
来源期刊：Current drug metabolismDOI：10.2174/1389200220666190618100847
Challenges in the Discovery of Novel Therapeutic Agents in Cancer.
来源期刊：Current drug metabolismDOI：10.2174/138920022012200102095006
Monocarboxylate transporter 1: A promising drug-delivery target in the treatment of brain diseases and cancers.
来源期刊：Current drug metabolismDOI：10.2174/1389200220666191021103018

相关文章

Materials Today Bio解析：IF=8.7，8天初审
2025-11-25
《ZEITSCHRIFT FUR GEBURTSHILFE UND NEONATOLOGIE》德国老牌产科期刊免版面费、非预警，毕业保底首选！
2025-11-25
Journal of Multidisciplinary Healthcare：IF= 2.4，中科院3区，JCR Q2，多学科综合医学开放获取期刊，应用性强，审稿迅速，编辑反馈专业！
2025-10-15
European Journal of Medical Genetics：IF= 1.7，中科院4区，JCR Q3，医学遗传学期刊，涵盖分子遗传学、临床基因诊断与罕见病研究，欧洲地区影响力较稳，国际传播适中！
2025-10-15
ANNALS OF ONCOLOGY：中科院1区，肿瘤学，接受率为25%
2025-10-15
Journal of Cystic Fibrosis：权威官方背景，高影响力，整体周期约 3 个月，部分 1 天录用
2025-10-15
JOURNAL OF INHERITED METABOLIC DISEASE：影响因子平稳，学术认可度高，年发文稳定，4个月录用
2025-10-15
JOURNAL OF OCCUPATIONAL AND ENVIRONMENTAL HYGIENE：自引风险小，审稿周期短，发表难度低，但if持续下降
2025-10-15
Neurobiology of Stress：中科院 2 区，认可度高，国人发文第二，机会公平
2025-10-15
NATURE REVIEWS DRUG DISCOVERY：中科院1区，生物工程与应用微生物，药学，接受率为21%
2025-10-15

期刊推荐

ACSMS HEALTH & FITNESS JOURNAL封面

ACSMS HEALTH & FITNESS JOURNAL

学科领域：医学
影响因子：1.8
中科院分区： 4区
ACTA BIOQUIMICA CLINICA LATINOAMERICANA封面

ACTA BIOQUIMICA CLINICA LATINOAMERICANA

学科领域：医学
影响因子：0.1
中科院分区： 4区
Acta Cardiologica Sinica封面

Acta Cardiologica Sinica

学科领域：医学
影响因子：1.8
中科院分区： 4区
Acta Chirurgiae Orthopaedicae et Traumatologiae Cechoslovaca封面

Acta Chirurgiae Orthopaedicae et Traumatologiae Cechoslovaca

学科领域：医学
影响因子：0.4
中科院分区： 4区
论文发表 2-4个月录用 7500+文章录用 不成功可退款
新
2026年3月发布（新锐分区）
大类学科小类学科Top期刊综述期刊
医学4区
BIOCHEMISTRY & MOLECULAR BIOLOGY 生化与分子生物学
4区
PHARMACOLOGY & PHARMACY 药学
4区
否
N/A
2025年3月升级版
大类学科小类学科Top期刊综述期刊
医学4区
BIOCHEMISTRY & MOLECULAR BIOLOGY 生化与分子生物学
4区
PHARMACOLOGY & PHARMACY 药学
4区
否
是
2023年12月旧的升级版
大类学科小类学科Top期刊综述期刊
医学4区
BIOCHEMISTRY & MOLECULAR BIOLOGY 生化与分子生物学
4区
PHARMACOLOGY & PHARMACY 药学
4区
否
是